Skip to main content

Advertisement

SpringerLink
Log in

Diabetes in African Americans: Unique pathophysiologic features

  • Published:
Current Diabetes Reports Aims and scope Submit manuscript

Abstract

Type 2 diabetes is an increasing public health problem among African Americans, especially children. Several features make type 2 diabetes among African Americans unique. First, African-American adults with type 2 diabetes, or Flatbush diabetes, present with diabetic ketoacidosis. Patients are insulin resistant with acute, severe defects in insulin secretion and no islet cell autoantibodies. Following treatment, some insulin secretory capacity is recovered and ketoacidosis generally does not recur. The second is remission in African Americans with type 2 diabetes. Recovery of glucose homeostasis, accompanied by recovery of β-cell function, follows intensive glycemic regulation. Finally, among African Americans with diabetes who are not obese, normal insulin sensitivity is not uncommon. Such individuals do not have the increased cardiovascular risk of insulin-resistant individuals. Differences in visceral, not subcutaneous, adipose tissue volume appear to determine insulin sensitivity. Understanding the unique physiologic and clinical features of African Americans is critical in designing appropriate treatment strategies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Harris MI, Flegal KM, Cowie CC, et al.: Prevalence of diabetes, impaired fasting glucose and impaired glucose tolerance in US adults. Diabetes Care 1998, 21:518–524.

    Article  CAS  PubMed  Google Scholar 

  2. Brancati FL, Kao WH, Folsom AR, et al.: Incident type 2 diabetes mellitus in African American and white adults: the Atherosclerosis Risk in Communities Study. JAMA 2000, 283:2253–2259.

    Article  CAS  PubMed  Google Scholar 

  3. Smedley BD,Stith AY,Nelson AR, eds: The healthcare environment and its relation to disparities. In Unequal Treatment: Confronting Racial and Ethnic Disparities in Health Care. Washington, DC: Institute of Medicine; 2003:80–124. http://www.nap.edu/catalog/10260.html.

  4. Banerji MA, Chaiken RL, Huey H, et al.: GAD antibody negative NIDDM in black subjects with diabetic ketoacidosis and increased frequency of human leukocyte antigen DR3 and DR4. Flatbush diabetes. Diabetes 1994, 43:741–745.

    Article  CAS  PubMed  Google Scholar 

  5. Banerji MA, Lebovitz HE: Remission in non-insulin-dependent diabetes mellitus: clinical characteristics of remission and relapse in black patients. Medicine 1990, 69:176–185.

    Article  CAS  PubMed  Google Scholar 

  6. Chaiken RL, Banerji MA, Pasmantier RM, et al.: Patterns of glucose and lipid abnormalities in black NIDDM subjects. Diabetes Care 1991, 14:1036–1042.

    Article  CAS  PubMed  Google Scholar 

  7. Banerji MA, Lebovitz HE: Insulin sensitive and insulin resistant variants in NIDDM. Diabetes 1989, 38:784–801.

    Article  CAS  PubMed  Google Scholar 

  8. Reaven GM: The role of insulin resistance in human disease. Diabetes 1988, 37:1595–1607.

    Article  CAS  PubMed  Google Scholar 

  9. McFarlane SI, Banerji MA, Sowers JR: Insulin resistance and cardiovascular risk. J Clin Endocrinol Metab 2001, 86:713–718.

    Article  CAS  PubMed  Google Scholar 

  10. Morrison EY, Ragoobirsingh D, Thompson H, et al.: Phasic insulin dependent diabetes: manifestations and cellular mechanisms. J Clin Endocrinol Metab 1995, 80:1996–2001.

    Article  CAS  PubMed  Google Scholar 

  11. Adadevoh BK: ‘Temporary diabetes’ in adult Nigerians. Trans R Soc Trop Med Hyg 1968, 62:528–530.

    Article  CAS  PubMed  Google Scholar 

  12. Katakawa M, Aizawa T, Naka M, et al.: Long-term prognosis of islet cell antibody negative ketosis onset diabetes with subsequent non-insulin dependency. Diabetes Care 1999, 22:1584–1586.

    Article  Google Scholar 

  13. Umpierrez GE, Casals MM, Gebhart SP, et al.: Diabetic ketoacidosis in obese African-Americans. Diabetes 1995, 44:790–795.

    Article  CAS  PubMed  Google Scholar 

  14. Sobngwi E, Vexiau P, Levy V, et al.: Metabolic and immunogenic prediction of long term remission in African patients either atypical diabetes. Diabet Med 2002, 19:832–835. Recovery of glucose homeostasis among patients of African origin in France.

    Article  CAS  PubMed  Google Scholar 

  15. Maldonado M, Hampe CS, Gaur LK, et al.: Ketosis prone diabetes: a dissection of a heterogeneous syndrome using immunogenetic and beta-cell functional classification, prospective analysis and clinical outcomes. J Clin Endocrinol Metab 2003, 88:5090–5098. An excellent characterization of insulin secretion and antibody status and the heterogeneity of adults presenting with DKA.

    Article  CAS  PubMed  Google Scholar 

  16. Balasubramanian A, Zern JW, Hyman DJ, Pavlik V: New profiles of diabetic ketoacidosis: type 1 and type 2 diabetes and the effect of ethnicity. Arch Intern Med 1999, 159:2317–2322.

    Article  Google Scholar 

  17. Umpierrez GE, Clark WS, Steen MT: Sulfonylurea treatment prevents recurrence of hyperglycemia in obese African-American patients with a history of hyperglycemic crises. Diabetes Care 1997, 20:479–483.

    Article  CAS  PubMed  Google Scholar 

  18. Banerji MA, Chaiken RL, Lebovitz HE: Long-term remission in NIDDM in blacks. Diabetes 1996, 45:337–341.

    Article  CAS  PubMed  Google Scholar 

  19. Kayashima T, Yamaguchi K, Konno Y, et al.: Effects of early introduction of intensive insulin therapy on the clinical course of non-obese NIDDM patients. Diabetes Res Clin Pract 1995, 28:119–125.

    Article  CAS  PubMed  Google Scholar 

  20. Ilkova H, Glaser B, Tackle A, et al.: Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment. Diabetes Care 1997, 20:1352–1356.

    Article  Google Scholar 

  21. Singer DL, Hurwitz D: Long-term experience with sulphonylureas and placebo. N Engl J Med 1967, 277:450–456.

    Article  CAS  PubMed  Google Scholar 

  22. Rendell M, Zariello J, Drew HM, et al.: Recovery from decompensated non-insulin dependent diabetes mellitus: studies of C-peptide secretion. Diabetes Care 1981, 4:354–359.

    Article  CAS  PubMed  Google Scholar 

  23. Lev-Ran A: Trial of placebo in long term chlorpropamide treated diabetics. Diabetologia 1974, 10:197–200.

    Article  CAS  PubMed  Google Scholar 

  24. Genuth SM: Clinical remission in diabetes mellitus. Studies of insulin secretion. Diabetes 1970, 19:116–121.

    CAS  PubMed  Google Scholar 

  25. Cheng TO, Jahraus RC, Traut EF: Extreme hyperglycemia and severe ketosis with spontaneous remission of diabetes mellitus. JAMA 1953, 152:1531–1533.

    CAS  Google Scholar 

  26. Peck FB Jr, Kirtley WR, Peck FB Sr: Complete remission of severe diabetes. Diabetes 1958, 7:93–97.

    PubMed  Google Scholar 

  27. Retinopathy and nephropathy in patients with type 1 diabetes for four years after a trial of intensive therapy. The diabetes control and complications trial. Epidemiology of diabetes interventions and complications research group [no authors listed]. N Engl J Med 2000, 342:381–388.

  28. Stratton IM, Adler AI, Neil HA, et al.: Association of glycaemia with macrovascular and microvascular complication of type 2 diabetes. UKPDS 350: prospective observational study. BMJ 2000, 321:405–412.

    Article  CAS  PubMed  Google Scholar 

  29. Khaw KT, Wareham N, Luben R, et al.: Glycated haemoglobin, diabetes and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk). BMJ 2001, 322:15–18.

    Article  CAS  PubMed  Google Scholar 

  30. Hirsch S, Norton M, Harrington P: Education increases rate of near normoglycemic remission in newly diagnosed NIDDM [abstract]. Diabetes 1995, 142 (suppl):25A.

    Google Scholar 

  31. Banerji MA, Chaiken RC, Lebovitz HE: Prolongation of near-normoglycemic remission in black NIDDM subjects with chronic low-dose sulfonylurea treatment. Diabetes 1995, 44:466–470.

    Article  CAS  PubMed  Google Scholar 

  32. Aguilar-Bryan L, Bryan J, Nakazaki M: Of mice and men: K(ATP) channels and insulin secretion. Recent Prog Horm Res 2001, 56:47–68.

    Article  CAS  PubMed  Google Scholar 

  33. McFarlane SI, Chaiken RL, Hirsch S, et al.: Near-normoglycaemic remission in African-Americans with type 2 diabetes mellitus is associated with recovery of beta-cell function. Diabet Med 2001, 18:10–16. A prospective clinical trial of intensive glycemic regulation and induction of remission.

    Article  CAS  PubMed  Google Scholar 

  34. Yi Jarvinen H: Glucose toxicity. Endocr Rev 1992, 13:415–431.

    Article  Google Scholar 

  35. McGarry JD: What if Minkowski had been ageusic? An alternate angle on diabetes. Science 1992, 258:766–770.

    Article  CAS  PubMed  Google Scholar 

  36. Haffner SM, D'Agostino R Jr, Mykkanen L, et al.: Insulin sensitivity in subjects with type 2 diabetes. Relationship to cardiovascular risk factors: the Insulin Resistance Atherosclerosis Study. Diabetes Care 1999, 22:562–568.

    Article  CAS  PubMed  Google Scholar 

  37. Banerji MA, Buckley MC, Chaiken RL, et al.: Liver fat, serum triglycerides and visceral adipose tissue in insulin-sensitive and insulin-resistant black men with NIDDM. Int J Obes Relat Metab Disord 1995, 19:846–850.

    CAS  PubMed  Google Scholar 

  38. Taniguchi A, Fukushima M, Sakai M, et al.: The role of the body mass index and triglyceride levels in identifying insulinsensitive and insulin-resistant variants in Japanese noninsulin-dependent diabetic patients. Metabolism 2000, 8:1001–1005.

    Article  Google Scholar 

  39. Grundy SM, Brewer HB, Cleeman JI, et al.: Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation 2004, 109:433–438.

    Article  PubMed  Google Scholar 

  40. Genuth S, Alberti KG, Bennett P, et al.: Follow-up on report on the diagnosis of diabetes mellitus. The Expert Committee on the Diagnosis and Classification of Diabetes mellitus. Diabetes Care 2003, 26:3160–3167.

    Article  PubMed  Google Scholar 

  41. Falkner B, Kushner H, Tulenko T, et al.: Insulin sensitivity, lipids, and blood pressure in young American blacks. Arterioscler Thromb Vasc Biol 1995, 11:1798–1804.

    Google Scholar 

  42. Chaiken RL, Banerji MA, Huey H, Lebovitz HE: Do blacks with NIDDM have an insulin-resistance syndrome? Diabetes 1993, 42:444–449.

    Article  CAS  PubMed  Google Scholar 

  43. Saad MF, Lillioja S, Nyomba BL, et al.: Racial differences in the relation between blood pressure and insulin resistance. N Engl J Med 1991, 324:733–739.

    Article  CAS  PubMed  Google Scholar 

  44. Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Final Report [no authors listed]. Circulation 2002, 106:3143–3421.

  45. Ford ES, Gale WH, Dietz WH: Prevalence of metabolic syndrome in US adults: findings of the third National Health and Nutrition Examination Survey. JAMA 2002, 287:356–359.

    Article  PubMed  Google Scholar 

  46. Laaka HM, Laaksonen DE, Laaka TA, et al.: The metabolic syndrome and cardiovascular mortality in middle-aged men. JAMA 2002, 288:2709–2716.

    Article  Google Scholar 

  47. Osei K, Rhinesmith S, Gaillard T, Schuster D: Is glycosylated hemoglobin A1c a surrogate for metabolic syndrome in nondiabetic, first-degree relatives of African-American patients with type 2 diabetes? J Clin Endocrinol Metab 2003, 88:4596–4601.

    Article  CAS  PubMed  Google Scholar 

  48. Schulman GI: Cellular mechanisms of insulin resistance. J Clin Invest 2000, 106:171–176.

    Article  Google Scholar 

  49. Evans JL, Goldfine ID, Maddux BA, Grodsky GM: Are oxidative stress-activated signal pathways mediators of insulin resistance and beta-cell dysfunction? Diabetes 2003, 52:1–8.

    Article  CAS  PubMed  Google Scholar 

  50. Sinha R, Fisch G, Teague B, et al.: Prevalence of impaired glucose tolerance among children and adolescents with marked obesity. N Engl J Med 2002, 346:802–810.

    Article  CAS  PubMed  Google Scholar 

  51. Arslanian S: Metabolic differences between Caucasian and African-American children and the relationship to type 2 diabetes mellitus. J Pediatr Endocrinol Metab 2002, 15(suppl 1):509–517. Review of the pathophysiology of diabetes in black and white children.

    PubMed  Google Scholar 

  52. Bacha F, Saad R, Gungor N, et al.: Obesity, regional fat distribution, and syndrome X in obese black versus white adolescents: race differential in diabetogenic and atherogenic risk factors. J Clin Endocrinol Metab 2003, 88:2534–2540.

    Article  CAS  PubMed  Google Scholar 

  53. Steinberger J, Daniels SR: Obesity, insulin resistance, diabetes, and cardiovascular risk in children: an American Heart Association scientific statement from the Atherosclerosis, Hypertension, and Obesity in the Young Committee (Council on Cardiovascular Disease in the Young) and the Diabetes Committee (Council on Nutrition, Physical Activity, and Metabolism). Circulation 2003, 107:1448–1453.

    Article  PubMed  Google Scholar 

  54. Apedo MT, Sowers JR, Banerji M: Cardiovascular disease in adolescents with type 2 diabetes mellitus. J Pediatr Endocrinol Metab 2002, 15(suppl 1):519–523.

    PubMed  Google Scholar 

  55. Banerji MA: Impaired beta-cell and alpha-cell function in African-American children with type 2 diabetes mellitus—‘Flatbush diabetes.’ J Pediatr Endocrinol Metab 2002, 15(suppl 1):493–501.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. SUNY Health Science Center, 450 Clarkson Avenue, Box 123, 11203, Brooklyn, NY, USA

    Mary Ann Banerji MD

Authors
  1. Mary Ann Banerji MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Banerji, M.A. Diabetes in African Americans: Unique pathophysiologic features. Curr Diab Rep 4, 219–223 (2004). https://doi.org/10.1007/s11892-004-0027-3

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11892-004-0027-3

Keywords

Search

Navigation